Skip to content

Construction and preliminary application of an exercise intervention program for patients with metabolically associated fatty liver disease

Development of an Exercise Behavior Promotion Intervention Program for Metabolic Associated Fatty Liver Disease (MAFLD) from the Perspective of Implementation Science

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121341
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MAFLD

Interventions

intervention group:Exercise prescription + Implementation strategy

Sponsors

The Third Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. Those who can visit the research site for t 3 times offline assessment during the study period; 3. Voluntary participants in this study; 4. Patients with MAFLD who have not yet reached the point requiring drug intervention as assessed by clinical experts.

Exclusion criteria

Exclusion criteria: 1. Those with symptoms or signs of cardiovascular and cerebrovascular diseases, such as chest tightness, shortness of breath, even chest pain, especially when climbing stairs or walking briskly; 2. Patients with combined cardiovascular and cerebrovascular diseases, lung/renal diseases or related complications; 3. Patients with severe diabetes or related complications, such as significant eye lesions affecting vision, peripheral nerve lesions affecting balance and coordination ability, diabetic foot patients, and patients with renal dysfunction; 4. Those with unstable blood sugar and blood pressure control, fasting blood glucose > 16.7 mmol/L; or post-meal blood glucose > 19.4 mmol/L; resting blood pressure = 160/100 mmHg; 5. Those with exercise contraindications, such as pregnancy or having musculoskeletal joint diseases; 6. Patients with severe cognitive dysfunction; 7. Those who cannot participate in follow-up for other reasons.

Design outcomes

Primary

MeasureTime frame
Exercise compliance score;

Secondary

MeasureTime frame
exercise self-efficacy;quality of life;body composition;athletic ability;

Countries

China

Contacts

Public ContactXinjuan Huang; Chunxiang Qin

Central South University; The third xiangya hospital of Central South University

1391352308@qq.com+86 186 9257 0527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026